Old Web
English
Sign In
Acemap
>
authorDetail
>
Stribling Ds
Stribling Ds
Merck & Co.
In vivo
Cannabinoid
Inverse agonist
Pharmacology
Taranabant
2
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery of N-[(4R)-6-(4-Chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist for the Treatment of Obesity
2010
Journal of Medicinal Chemistry
Lin Yan
Pei Huo
John S. Debenham
Christina B. Madsen-Duggan
Julie Lao
Richard Z. Chen
Jing Chen Xiao
Chun-Pyn Shen
Stribling Ds
Lauren P. Shearman
Alison M. Strack
Nancy N. Tsou
Richard G. Ball
Junying Wang
Xinchun Tong
Thomas Bateman
Vijay Bhasker G. Reddy
Tung M. Fong
Jeffrey J. Hale
Show All
Source
Cite
Save
Citations (15)
Pharmacological efficacy and safety profile of taranabant in preclinical species
2009
Drug Development Research
Tung M. Fong
Lauren P. Shearman
Stribling Ds
J. Shu
Julie Z. Lao
Cathy C.R.-R. Huang
Jing Chen Xiao
Chun-Pyn Shen
J. Tyszkiewicz
Alison M. Strack
C. DeMaula
M.-F. Hubert
A. Galijatovic-Idrizbegovic
R. Owen
A.C. Huber
C.L. Lanning
Show All
Source
Cite
Save
Citations (14)
1